Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Regenass

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activityE Buchdunger, U Trinks, H Mett, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1998
RetractionsE Buchdunger, U Trinks, H Mett, et al.
Journal of Medicinal Chemistry|August 1, 1991
Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinaseP M Traxler, O Wacker, H L Bach, et al.
Oncogene|December 21, 2010
Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addictionM Colombi, K D Molle, D Benjamin, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activityE Buchdunger, U Trinks, H Mett, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1998
RetractionsE Buchdunger, U Trinks, H Mett, et al.
Journal of Medicinal Chemistry|August 1, 1991
Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinaseP M Traxler, O Wacker, H L Bach, et al.
Oncogene|December 21, 2010
Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addictionM Colombi, K D Molle, D Benjamin, et al.
Pageof 4